Marshall Wace, LLP Cerus Corp Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Cerus Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 378,541 shares of CERS stock, worth $685,159. This represents 0.0% of its overall portfolio holdings.
Number of Shares
378,541
Previous 211,071
79.34%
Holding current value
$685,159
Previous $367,000
58.58%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CERS
# of Institutions
159Shares Held
146MCall Options Held
48.6KPut Options Held
8.7K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl20.8MShares$37.7 Million0.28% of portfolio
-
Baker Bros. Advisors LP New York, NY19.5MShares$35.3 Million0.33% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$25.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.4MShares$18.9 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.32MShares$15.1 Million0.06% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $321M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...